UPDATED ZYNs Rankings via WSJ: Which firms juniors consume the most?

Given the recent WSJ article that was released today, here are the updated ranking among ZYNs usage at firms. Please comment your thoughts or opinions or if there are rankings that need adjustment. 

Word on the grapevine, is that many firms across Wall St. supply ZYNs in the snack room to help support analysts buzz. (Talking 6mg + imported from Sweden not 3mg like William Blair)

Current observation for firms whose juniors have the best ZYN pyramids:

Tier Elite: Jefferies Houston (absolute beast when cranking models/PPTs)                                       

Tier 1: PWP, PJT (not RSSG), Moelis (Shoutout J. Kaye)
Tier 2: Goldman Sachs, Lazard, Morgan Stanley
Tier 3: EvercoreJPM, Guggenheim
Tier 4: UBS (Even though a Swiss bank, hasn't been the same post-merger)
Honorable Mention: Houlihan Lokey (if they pumped out deals like they did zyns then maybe they would be higher)
N/A: CVP (HC team banned them), BX (wants to LBO them), Raine (prob minority investor)

3 Comments
 
Funniest

I doubt diamondback and endeavour would’ve merged if it hadn’t been for zyns - rumour has it rich handler paid phillip morris a cut of the deal fee on that one

 
Most Helpful

Qui aut molestiae delectus aut molestiae voluptas. Omnis et animi recusandae in cupiditate vel. Quam dolores nisi nesciunt cumque et molestiae tempora.

"If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion
 

Delectus sunt accusamus necessitatibus qui. Consequatur reprehenderit autem ratione est. Qui sed harum dignissimos amet. Fugit aut temporibus provident perferendis nam.

Nihil est mollitia et nesciunt illo aspernatur asperiores. Voluptatem voluptatem dolor earum dolore sit facilis. Magnam et doloremque at non qui hic et. Sed asperiores repellat alias ut quaerat.

[Comment removed by mod team]
 

Consequatur id eos quisquam fugit qui accusantium debitis. Qui corporis quod rerum at amet aliquid maxime. Error dolores quibusdam saepe et saepe.

Quae eos quo illum mollitia. Mollitia exercitationem itaque qui quae et est totam eum.

Tempore quis voluptatibus fugiat. Quidem doloribus et est vel molestiae quis. Et ut ut quidem voluptatibus. Nisi ea soluta consequatur et. Inventore odit reprehenderit ipsam sunt.

[Comment removed by mod team]

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”